2582-354X
Full Text (PDF)
Review Article

Pharmacological Management of Negative Symptoms in Schizophrenia

Suprakash Chaudhury, Professor & Head, Department of Psychiatry, Dr DY Patil Medical College, Dr DY Patil Vidyapeeth, Pimpri, Pune, Maharashtra 411018, India. , Suprakash Chaudhury1 , Subodh Kumar2 , Biswajit Jagtap3 , Daniel Saldanha4

Author Information

Licence:




RFP Indian Journal of Medical Psychiatry 4(1):p 9-20, January – June 2021. | DOI:

How Cite This Article:

Suprakash Chaudhury, Subodh Kumar, Biswajit Jagtap, Daniel Saldanha/Pharmacological Management of
Negative Symptoms in Schizophrenia/RFP Indian Journal of Medical Psychiatry. 2021;4(1):9–20.
 


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Emotional blunting, alogia, avolition, a sociality and anhedonia are features of negative symptoms. Negative symptoms are blamed for poor outcome and persistent disability in schizophrenia. The high hopes of cure of negative symptoms by SGAs have been belied. Due to the complex nature of negative symptoms, several methodological issues are raised and it is treated with different antipsychotics and novel agents with varied results. The development of innovative treatment and increased collaboration is needed to overcome the current limitation. Keywords: Negative Symptoms; First Generation Antipsychotics; Second Generation Antipsychotics.


References

No records found.


About this article


Cite this article

Suprakash Chaudhury, Subodh Kumar, Biswajit Jagtap, Daniel Saldanha/Pharmacological Management of
Negative Symptoms in Schizophrenia/RFP Indian Journal of Medical Psychiatry. 2021;4(1):9–20.
 


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Tuesday 07 July 2026, 08:26:06 (IST)


492

Accesses

1
146
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share